These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 31125601)

  • 1. Histone deacetylase 6 inhibitor tubastatin A attenuates angiotensin II-induced hypertension by preventing cystathionine γ-lyase protein degradation.
    Chi Z; Byeon HE; Seo E; Nguyen QT; Lee W; Jeong Y; Choi J; Pandey D; Berkowitz DE; Kim JH; Lee SY
    Pharmacol Res; 2019 Aug; 146():104281. PubMed ID: 31125601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystathionine γ-lyase protects vascular endothelium: a role for inhibition of histone deacetylase 6.
    Leucker TM; Nomura Y; Kim JH; Bhatta A; Wang V; Wecker A; Jandu S; Santhanam L; Berkowitz D; Romer L; Pandey D
    Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H711-H720. PubMed ID: 28188215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Honokiol ameliorates angiotensin II-induced hypertension and endothelial dysfunction by inhibiting HDAC6-mediated cystathionine γ-lyase degradation.
    Chi Z; Le TPH; Lee SK; Guo E; Kim D; Lee S; Seo SY; Lee SY; Kim JH; Lee SY
    J Cell Mol Med; 2020 Sep; 24(18):10663-10676. PubMed ID: 32755037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes.
    Choi SY; Ryu Y; Kee HJ; Cho SN; Kim GR; Cho JY; Kim HS; Kim IK; Jeong MH
    Vascul Pharmacol; 2015 Sep; 72():130-40. PubMed ID: 25921924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II downregulates vascular endothelial cell hydrogen sulfide production by enhancing cystathionine γ-lyase degradation through ROS-activated ubiquitination pathway.
    Bai L; Qi Y; Chen S; Wang J; Tang C; Du J; Jin H; Huang Y
    Biochem Biophys Res Commun; 2019 Jun; 514(3):907-912. PubMed ID: 31084929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema.
    Yu J; Ma Z; Shetty S; Ma M; Fu J
    Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L39-47. PubMed ID: 27190059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC6 inhibition induces the failure of mouse early embryonic development.
    Wang H; Ling L; Ai L; Bai L
    J Cell Physiol; 2019 Jun; 234(6):8752-8759. PubMed ID: 30370558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of HDAC6 by Tubastatin A reduces chondrocyte oxidative stress in chondrocytes and ameliorates mouse osteoarthritis by activating autophagy.
    Shen Z; Ji K; Cai Z; Huang C; He X; Xu H; Chen G
    Aging (Albany NY); 2021 Mar; 13(7):9820-9837. PubMed ID: 33744850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Effects of HDAC6 Inhibition Versus Knockout During Hepatic Ischemia-Reperfusion Injury Highlight Importance of HDAC6 C-terminal Zinc-finger Ubiquitin-binding Domain.
    Concors SJ; Hernandez PT; O'Brien C; DePaolo J; Murken DR; Aufhauser DD; Wang Z; Xiong Y; Krumeich L; Ge G; Beier UH; Bhatti TR; Kozikowski AP; Avelar LAA; Kurz T; Hancock WW; Levine MH
    Transplantation; 2024 Oct; 108(10):2084-2092. PubMed ID: 38685198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness.
    Leyk J; Daly C; Janssen-Bienhold U; Kennedy BN; Richter-Landsberg C
    Cell Death Dis; 2017 Aug; 8(8):e3028. PubMed ID: 29048427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia/reperfusion injury by limiting tumour necrosis factor alpha-induced mitochondrial injury in experimental diabetes.
    Baumgardt SL; Fang J; Fu X; Liu Y; Xia Z; Zhao M; Chen L; Mishra R; Gunasekaran M; Saha P; Forbess JM; Bosnjak ZJ; Camara AKS; Kersten JR; Thorp EB; Kaushal S; Ge ZD
    Cardiovasc Res; 2024 Oct; 120(12):1456-1471. PubMed ID: 39001869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HDAC6 by tubastatin A disrupts mouse oocyte meiosis via regulating histone modifications and mRNA expression.
    Sui L; Huang R; Yu H; Zhang S; Li Z
    J Cell Physiol; 2020 Oct; 235(10):7030-7042. PubMed ID: 32017059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of transcription factor XBP1s in the resistance of HDAC6 inhibitor Tubastatin A to superoxidation via acetylation-mediated proteasomal degradation.
    Zhang Y; Liu CM; Cao XC; Zang Y; Zhou YB; Li J
    Biochem Biophys Res Commun; 2014 Jul; 450(1):433-9. PubMed ID: 24909686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury.
    Tang J; Shi Y; Liu N; Xu L; Zang X; Li P; Zhang J; Zheng X; Qiu A; Zhuang S
    Clin Sci (Lond); 2018 Feb; 132(3):339-359. PubMed ID: 29358506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC6-mediated deacetylation of FLOT2 maintains stability and tumorigenic function of FLOT2 in nasopharyngeal carcinoma.
    Luo C; Wen B; Liu J; Yang W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 May; 49(5):687-697. PubMed ID: 39174882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HDAC6 increases acetylation of peroxiredoxin1/2 and ameliorates 6-OHDA induced dopaminergic injury.
    Jian W; Wei X; Chen L; Wang Z; Sun Y; Zhu S; Lou H; Yan S; Li X; Zhou J; Zhang B
    Neurosci Lett; 2017 Sep; 658():114-120. PubMed ID: 28823893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of MET signaling by HDAC6 offers a rationale for a novel ricolinostat and crizotinib combinatorial therapeutic strategy in diffuse large B-cell lymphoma.
    Liu Z; Cai Y; Yang Y; Li A; Bi R; Wang L; Shen X; Wang W; Jia Y; Yu B; Cao B; Cui W; Wei P; Zhou X
    J Pathol; 2018 Oct; 246(2):141-153. PubMed ID: 29876933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.
    Shi Y; Xu L; Tang J; Fang L; Ma S; Ma X; Nie J; Pi X; Qiu A; Zhuang S; Liu N
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F502-F515. PubMed ID: 28052874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects.
    Vishwakarma S; Iyer LR; Muley M; Singh PK; Shastry A; Saxena A; Kulathingal J; Vijaykanth G; Raghul J; Rajesh N; Rathinasamy S; Kachhadia V; Kilambi N; Rajgopal S; Balasubramanian G; Narayanan S
    Int Immunopharmacol; 2013 May; 16(1):72-8. PubMed ID: 23541634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson's disease.
    Pinho BR; Reis SD; Guedes-Dias P; Leitão-Rocha A; Quintas C; Valentão P; Andrade PB; Santos MM; Oliveira JM
    Pharmacol Res; 2016 Jan; 103():328-39. PubMed ID: 26657418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.